341 related articles for article (PubMed ID: 10366082)
1. Efficacy of apraclonidine 1% versus pilocarpine 4% for prophylaxis of intraocular pressure spike after argon laser trabeculoplasty.
Ren J; Shin DH; Chung HS; Birt CM; Glover BK; Juzych MS; Hughes BA; Kim C
Ophthalmology; 1999 Jun; 106(6):1135-9. PubMed ID: 10366082
[TBL] [Abstract][Full Text] [Related]
2. Apraclonidine 0.5% versus brimonidine 0.2% for the control of intraocular pressure elevation following anterior segment laser procedures.
Chevrier RL; Assalian A; Duperré J; Lesk MR
Ophthalmic Surg Lasers; 1999 Mar; 30(3):199-204. PubMed ID: 10100253
[TBL] [Abstract][Full Text] [Related]
3. Control of intraocular pressure elevations after argon laser trabeculoplasty: comparison of brimonidine 0.2% to apraclonidine 1.0%.
Barnes SD; Campagna JA; Dirks MS; Doe EA
Ophthalmology; 1999 Oct; 106(10):2033-7. PubMed ID: 10519604
[TBL] [Abstract][Full Text] [Related]
4. Chronic use of apraclonidine decreases its moderation of post-laser intraocular pressure spikes.
Chung HS; Shin DH; Birt CM; Kim C; Lee D; Levin DS; Hakimzadeh R; Juzych MS
Ophthalmology; 1997 Nov; 104(11):1921-5. PubMed ID: 9373127
[TBL] [Abstract][Full Text] [Related]
5. Apraclonidine 0.5% versus 1% for controlling intraocular pressure elevation after argon laser trabeculoplasty.
Threlkeld AB; Assalian AA; Allingham RR; Shields MB
Ophthalmic Surg Lasers; 1996 Aug; 27(8):657-60. PubMed ID: 8858630
[TBL] [Abstract][Full Text] [Related]
6. The rarity of clinically significant rise in intraocular pressure after laser peripheral iridotomy with apraclonidine.
Lewis R; Perkins TW; Gangnon R; Kaufman PL; Heatley GA
Ophthalmology; 1998 Dec; 105(12):2256-9. PubMed ID: 9855156
[TBL] [Abstract][Full Text] [Related]
7. Argon laser trabeculoplasty medical therapy to prevent the intraocular pressure rise associated with argon laser trabeculoplasty.
Robin AL
Ophthalmic Surg; 1991 Jan; 22(1):31-7. PubMed ID: 2014108
[TBL] [Abstract][Full Text] [Related]
8. Micropulse diode laser (810 nm) versus argon laser trabeculoplasty in the treatment of open-angle glaucoma: comparative short-term safety and efficacy profile.
Detry-Morel M; Muschart F; Pourjavan S
Bull Soc Belge Ophtalmol; 2008; (308):21-8. PubMed ID: 18700451
[TBL] [Abstract][Full Text] [Related]
9. Primary argon laser trabeculoplasty vs pilocarpine 2% in primary open angle glaucoma: two years follow-up study.
Sharma A; Gupta A
Indian J Ophthalmol; 1997 Jun; 45(2):109-13. PubMed ID: 9475029
[TBL] [Abstract][Full Text] [Related]
10. Perioperative medications for preventing temporarily increased intraocular pressure after laser trabeculoplasty.
Zhang L; Weizer JS; Musch DC
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD010746. PubMed ID: 28231380
[TBL] [Abstract][Full Text] [Related]
11. Brimonidine 0.15% versus apraclonidine 0.5% for prevention of intraocular pressure elevation after anterior segment laser surgery.
Chen TC
J Cataract Refract Surg; 2005 Sep; 31(9):1707-12. PubMed ID: 16246772
[TBL] [Abstract][Full Text] [Related]
12. Brinzolamide 1% versus apraclonidine 0.5% to prevent intraocular pressure elevation after neodymium:YAG laser posterior capsulotomy.
Unal M; Yücel I; Akar Y
J Cataract Refract Surg; 2006 Sep; 32(9):1499-502. PubMed ID: 16931262
[TBL] [Abstract][Full Text] [Related]
13. Reversal of intraocular pressure increases with 0.5% apraclonidine after dilated fundus examination in patients with chronic open-angle glaucoma.
Nishimoto JH; Chang FW; Tang IH; Kolin T
J Am Optom Assoc; 1999 Apr; 70(4):233-9. PubMed ID: 10457699
[TBL] [Abstract][Full Text] [Related]
14. Comparing brimonidine 0.2% to apraclonidine 1.0% in the prevention of intraocular pressure elevation and their pupillary effects following laser peripheral iridotomy.
Yuen NS; Cheung P; Hui SP
Jpn J Ophthalmol; 2005; 49(2):89-92. PubMed ID: 15838723
[TBL] [Abstract][Full Text] [Related]
15. [Pressure reduction after selective laser trabeculoplasty with two different laser systems and after argon laser trabeculoplasty--a controlled prospective clinical trial on 284 eyes].
Best UP; Domack H; Schmidt V
Klin Monbl Augenheilkd; 2007 Mar; 224(3):173-9. PubMed ID: 17385117
[TBL] [Abstract][Full Text] [Related]
16. Comparison of long-term outcomes of selective laser trabeculoplasty versus argon laser trabeculoplasty in open-angle glaucoma.
Juzych MS; Chopra V; Banitt MR; Hughes BA; Kim C; Goulas MT; Shin DH
Ophthalmology; 2004 Oct; 111(10):1853-9. PubMed ID: 15465546
[TBL] [Abstract][Full Text] [Related]
17. Influence of apraclonidine and pilocarpine alone and in combination on post laser trabeculoplasty pressure rise.
Dapling RB; Cunliffe IA; Longstaff S
Br J Ophthalmol; 1994 Jan; 78(1):30-2. PubMed ID: 7906539
[TBL] [Abstract][Full Text] [Related]
18. Early intraocular pressure response to laser trabeculoplasty 180 degrees without apraclonidine versus 360 degrees with apraclonidine.
Allf BE; Shields MB
Ophthalmic Surg; 1991 Sep; 22(9):539-42. PubMed ID: 1682861
[TBL] [Abstract][Full Text] [Related]
19. Topical apraclonidine hydrochloride in eyes with poorly controlled glaucoma. The Apraclonidine Maximum Tolerated Medical Therapy Study Group.
Robin AL; Ritch R; Shin D; Smythe B; Mundorf T; Lehmann RP
Trans Am Ophthalmol Soc; 1995; 93():421-38; discussion 439-41. PubMed ID: 8719690
[TBL] [Abstract][Full Text] [Related]
20. Effect of Apraclonidine and Diclofenac on Early Changes in Intraocular Pressure After Selective Laser Trabeculoplasty.
Thrane VR; Thrane AS; Bergo C; Halvorsen H; Krohn J
J Glaucoma; 2020 Apr; 29(4):280-286. PubMed ID: 32053556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
